Pathfinders in Biopharma Podcast
Stay ahead of the curve with the latest perspectives from the cutting edge of biotech and pharma.
More from RBC Capital Markets
Recent Transactions
US $600 million
PACS Group completes follow-on offering
Joint Bookrunner
US $302 million
IDEAYA completes upsized follow-on offering
Joint Bookrunner
US $250 million
Sale of Valinor Pharma to Grünenthal
Lead Financial Advisor
US $192 million
Ardent Health Partners completes initial public offering
Joint Bookrunner
US $500 million
Intra-Cellular Therapies completes follow-on offering
Joint Bookrunner
US $70 million
Korro Bio completes private placement
Placement Agent
US $110 million
Contineum completes follow-on offering
Joint Bookrunner
Undisclosed
Apax Partners agrees to sell Clinisupplies
Exclusive Financial Advisor / Pending
US $35.6 million
Societal CDMO’s $35.6 million follow-on offering
Sole Bookrunner
Undisclosed
IFM Investors acquires PRP Diagnostic Imaging
Exclusive Financial Advisor
US $575 million
Surgery Partners’ $575 million follow-on offering
Bookrunner
US $60 million
Marinus Pharmaceuticals $60 million follow-on offering
Joint Bookrunner
Undisclosed
SK Capital acquires Apotex
Lead Financial Advisor
Lead Today. Define Tomorrow.™
From insights and advisory services to excellence in execution, we are an innovative, trusted partner in capital markets, banking, and finance.
Stay Informed
Get the latest insights from RBC Capital Markets delivered to your inbox.